No black box warning on record for Phesgo
As of the latest FDA labeling reviewed, Phesgo (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF) does not carry a black box warning. Standard warnings and precautions still apply — see the full Phesgo medicine page for the complete safety profile.